Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00200018 · ClinicalTrials.gov registry record · NA
Study of Weight Loss Using Gastric Stimulation in Obese Patients With Type 2 Diabetes
A NA study, sponsored by MedtronicNeuro.
- Completed
- Registry status
- NA
- Development phase
- 46
- Enrollment target
NCT00200018 is a NA study that has completed, run by MedtronicNeuro. The registered enrollment target is 46 participants.
The verdict
NCT00200018, a NA study, has completed, sponsored by MedtronicNeuro.
- COMPLETED
- Registry status
- NA
- Development phase
- 46 participants
- Enrollment target
Study Summary
The purpose of this study is to test the effect of an implanted device that stimulates the stomach on weight loss in patients suffering from obesity and type 2 diabetes.
Interventions
- DEVICE Enterra Therapy System (H9900014)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 46 participants |
| Start Date | 2005-06 |
| Est. Completion | 2007-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00200018
The ClinicalTrials.gov registry entry for NCT00200018 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 46 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is MedtronicNeuro, which has 51 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Enterra Therapy System (H9900014) is the first listed.
NCT00200018 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00200018 about?
NCT00200018 is a clinical study titled "Study of Weight Loss Using Gastric Stimulation in Obese Patients With Type 2 Diabetes". The purpose of this study is to test the effect of an implanted device that stimulates the stomach on weight loss in patients suffering from obesity and type 2 diabetes.
What is the current status of trial NCT00200018?
This trial is currently completed. It is a NA study. The enrollment target is 46 participants. The study started on 2005-06. Estimated completion is 2007-12.
What interventions are being tested in trial NCT00200018?
The interventions under investigation include: Enterra Therapy System (H9900014) (DEVICE).
Who is sponsoring clinical trial NCT00200018?
This trial is sponsored by MedtronicNeuro, which has 51 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.